Reducing the burden of maternal and child morbidity and mortality in the Eastern Mediterranean Region? Yes, we can.

East Mediterr Health J

Professor of Obstetrics and Gynaecology, Department of Obstetrics and Gynaecology, University of Assiut, Assiut, Egypt.

Published: February 2014

AI Article Synopsis

  • Maternal and child morbidity and mortality pose significant public health challenges in the WHO Eastern Mediterranean Region, which includes a mix of high-, middle-, and low-income countries facing political and development issues.
  • Progress on Millennium Development Goals 4 and 5 has been inconsistent, highlighting the need for targeted analysis of strengths, weaknesses, opportunities, and threats in improving health outcomes.
  • To reduce these health burdens, a strong commitment to collaboration is essential among countries and international bodies.

Article Abstract

Maternal and child morbidity and mortality are a major public health, development and human rights challenge globally and in the WHO Eastern Mediterranean Region. The Region is diverse, with high-, middle- and low- income countries, many suffering from political instability, conflicts and other complex development challenges. Although progress has been made towards Millennium Development Goals 4 and 5, it has been uneven both between and within countries. This paper makes an analysis of the strengths, weaknesses, opportunities and threats to improving maternal and child mortality and morbidity with a focus on the Region. In answer to the question whether we can reduce the burden of maternal and child morbidity and mortality in the Region: yes, we can. However, commitment and collaboration are needed at the country, regional and international levels.

Download full-text PDF

Source

Publication Analysis

Top Keywords

maternal child
16
child morbidity
12
morbidity mortality
12
burden maternal
8
eastern mediterranean
8
reducing burden
4
maternal
4
child
4
morbidity
4
mortality
4

Similar Publications

Study Question: Is elevated plasma molybdenum level associated with increased risk for idiopathic premature ovarian insufficiency (POI)?

Summary Answer: Elevated plasma molybdenum level is associated with an increased risk of idiopathic POI through vascular endothelial injury and inhibition of granulosa cell proliferation.

What Is Known Already: Excessive molybdenum exposure has been associated with ovarian oxidative stress in animals but its role in the development of POI remains unknown.

Study Design, Size, Duration: Case-control study of 30 women with idiopathic POI and 31 controls enrolled from August 2018 to May 2019.

View Article and Find Full Text PDF

Study Question: Are empirically derived adolescent overweight/obesity phenotypes differentially associated with polycystic ovary syndrome (PCOS) in young adulthood?

Summary Answer: Self-reported PCOS diagnosis risk in young adulthood varied by empirically derived adolescent overweight/obesity phenotypes, with the highest risk observed among those in the 'mothers with obesity' and 'early puberty' phenotypes.

What Is Known Already: Overweight and obesity during puberty are postulated to promote the development of PCOS. Much of the prior literature in this area is cross-sectional and defines weight status based solely on BMI, yet emerging research suggests that not all people with overweight/obesity have the same risk for chronic health conditions, including PCOS.

View Article and Find Full Text PDF

Youth living with HIV (YLWH) have high rates of virologic failure due to medication non-adherence. is a novel, gamified mobile health (mHealth) application designed with user-centered principles to improve medication adherence by integrating medication reminders with social and financial incentives, virtual peer social support and early clinic outreach for non-adherent YLWH in Nigeria. Focus Group Discussions (FGDs) were conducted to identify reactions to key prototype features (user interface, medication reminders, incentives, and peer support), facilitators and barriers to app use, and how well the app would meet adherence needs.

View Article and Find Full Text PDF

A low pre-existing anti-NS1 humoral immunity to DENV is associated with microcephaly development after gestational ZIKV exposure.

PLoS Negl Trop Dis

January 2025

División de Inmunología, Programa de Medicina, Facultad de Ciencias de la Salud, Universidad Surcolombiana, Neiva, Huila, Colombia.

Background: Gestational Zika virus (ZIKV) infection is associated with the development of congenital Zika syndrome (CZS), which includes microcephaly and fetal demise. The magnitude and quality of orthoflavivirus-specific humoral immunity have been previously linked to the development of CZS. However, the role of ZIKV NS1-specific humoral immunity in mothers and children with prenatal ZIKV exposure and CZS remains undefined.

View Article and Find Full Text PDF

A Lipidomic Study to Identify the Serum Lipid Markers for Obstetric Antiphospholipid Syndrome.

J Proteome Res

January 2025

Department of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210000, Jiangsu, China.

This study used untargeted lipidomics to analyze the characteristics of lipid metabolism in the serum of women with antiphospholipid syndrome. Twenty female patients with APS and 20 healthy controls were recruited to this study. Untargeted lipidomics with liquid chromatography-tandem mass spectrometry was used to profile serum lipids.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!